PGY1 Pharmacy Residency


PGY1 Program Purpose: PGY1 pharmacy residency programs build on Doctor of Pharmacy (Pharm.D.) education and outcomes to contribute to the development of clinical pharmacists responsible for medication-related care of patients with a wide range of conditions, eligible for board certification, and eligible for postgraduate year two (PGY2) pharmacy residency training.

This PGY1 position provides the resident with the academic rank of Clinical Instructor with the University of Oklahoma College of Pharmacy.  In this role, residents are given opportunities for didactic and experiential teaching to pharmacy students. Residents are also provided opportunities in rotation practice sites to provide in-formal and formal presentations to other members of the health-care team. The OU College of Pharmacy also offers a teaching certificate program (i.e., Foundational Teaching Skills for Residents) to give our residents a learning experience that provides basic knowledge of the skills required for effective teaching and also offers a diversity of opportunities for applying and practicing these skills. The skills acquired in this program can be applied to didactic lectures, clinical presentations, and platform presentations.


The PGY1 residents at the University of Oklahoma Health Sciences Center/OU Health residency training program are required to be rated as "Achieved" for 80% of the required objectives for the program. These include the objectives listed under the four required competency areas (i.e., patient care; advancing practice and improving patient care; leadership and management; and teaching, education, and dissemination of knowledge) as well as those listed under the selected competency area (i.e., Teaching and Learning). All of the R1 Patient Care goals and objectives must be rated as “Achieved for Residency” to successfully complete the PGY1 Pharmacy Residency program. 

Practice Sites

OU Health consists of two hospitals: OU Health University of Oklahoma Medical Center and Oklahoma Children’s Hospital OU Health. The primary residency practice site is OU Health University of Oklahoma Medical Center, a 515-bed teaching hospital that is the central training facility for physicians in the state of Oklahoma. In addition to a Level 1 trauma center, general medicine and surgical services, OU Health University of Oklahoma Medical Center has a variety of subspecialties including: cardiology, neurology, nephrology, hematology, oncology, and bone marrow transplant. The Children’s Hospital OU Health is the only comprehensive children’s hospital in the state of Oklahoma. It is a 314-bed teaching hospital with a 96-bed neonatal ICU, a 34-bed medical ICU, and 25-bed cardiovascular ICU. 

Outpatient practice sites include: Infectious Diseases Institute Clinic, General Internal Medicine Clinic, OU Health Stephenson Oklahoma Cancer Center, Variety Care Federally Qualified Health Center, and the Comprehensive Medication Management Clinic at Baptist-Integris Medical Center.

Professional Meetings

PGY1 Pharmacy residents attend one national and one regional meeting during the year. Residents travel to the ASHP Midyear Clinical Meeting in December to present their research projects as a poster and participate in the Residency Showcase. In the spring, residents will present a platform presentation at the Oklahoma Residency Research Conference hosted by the Oklahoma Society for Health System Pharmacists.

Residency Learning Experiences

  • Orientation to OU College of Pharmacy and OU Health – 1 month

    During the first month of the program, the resident participates in orientation activities at the OU College of Pharmacy and OU Health. The resident will attend a 2-day College of Pharmacy orientation and complete a documentation checklist to ensure initial documents and residency requirements are met. In addition, this rotation is designed to familiarize the resident with the primary practice site and to prepare the resident to function as a staff pharmacist in the inpatient setting. Residents begin training in investigational drugs and drug information during this month in addition to completing institutional review board requirements for conducting research. 

  • Clinical Staffing Orientation – 1 month

    This rotation will take place over 2-3 weeks in December and is designed to expose the resident to the roles and responsibilities of the clinical pharmacy specialists in an effort to prepare the resident for their clinical staffing weekend shifts in the Spring semester of their longitudinal staffing requirement. This rotation month also includes attendance at the ASHP Midyear Clinical Meeting.

  • Ambulatory Care – 1 month

    There are four options available (Infectious Disease Institute Clinic, Ambulatory Care at Variety Care Federally Qualified Health Center, Oncology Clinics at OU Health Stephenson Cancer Center, or General Internal Medicine Clinic at OU Health Physicians) for the required one-month ambulatory care rotation. The resident can preference rotations based on interest. Depending on the site selected, the resident is introduced to the outpatient management of thromboembolic disorders, diabetes, infectious diseases, oncologic conditions, as well as co-morbid diseases such as hypertension and dyslipidemia or the management of patients with HIV or other infectious complications. Additionally, the resident may also be involved in transitions of care to and from the inpatient setting. Additional options for ambulatory care rotations can be explored based on interest of resident and availability of preceptors.

  • Inpatient Internal Medicine – 1 month

    The internal medicine rotation is designed to promote the development of skills necessary to provide comprehensive pharmaceutical care services to internal medicine inpatients. The pharmacy resident joins a medicine teaching team consisting of physicians, physician trainees, the pharmacist preceptor, and pharmacy trainees. Patients assigned to the internal medicine teaching teams present with a wide variety of disease states including but not limited to diabetes, hypertension, heart failure, end-stage liver disease, and lower respiratory tract infections.

  • Critical Care – 1 month

    There are three options for the required critical Care rotation, which include the Medical Intensive Care Unit, Pediatric Medical Intensive Care Unit, or Trauma Intensive Care Unit. The critical care rotation is designed to provide the resident with an opportunity to be exposed to the management and care of critically-ill patients.  The pharmacy resident will be a member of a teaching team composed of medical students, mid-level practitioners, medical residents, and an attending physician. The resident will be exposed to disease states and/or topic discussions including sepsis/septic shock, ICU related infections (e.g., ventilator associated pneumonia) inotropes and vasopressors, sedation, analgesia, and neuromuscular blockers.

  • Inpatient Infectious Diseases - 1 month

    The inpatient infectious diseases rotation is designed to provide the resident with an opportunity to design, monitor, and re-design patient specific infectious diseases pharmacotherapy for patients on the infectious disease consult service. The pharmacy resident will be a member of a teaching team that includes an infectious disease attending physician, infectious diseases fellow, and internal medicine residents. The resident will be exposed to a variety of disease states/infections including endocarditis, opportunistic infections, meningitis, multi-drug resistant infections, and invasive fungal infections.

  • General Pediatrics – 1 month

    The general pediatric rotation is designed to provide the resident with exposure to disease states and various pharmacotherapy topics in children. The pharmacy resident will join a teaching team composed of medical students, medical residents, and an attending physician. Residents will be exposed to a variety of disease states including but not limited to asthma, sepsis work-up, a variety of viral and bacterial infections, bronchiolitis, seizure disorders, and pediatric pain management.

  • Practice Management – 1 month

    The practice management rotation allows the resident to participate in institutional programs and activities involving the medical and pharmacy staff, as well as adherence to established practices, procedures, and policies of the institutions and affiliated hospitals. During the rotation month, the resident will attend meetings with the pharmacy management team and will complete projects as needed in preparation for those meetings. Longitudinally, the residents are assigned to institutional committees and are expected to actively participate in committee activities as well as other development experiences at OU Health and OU College of Pharmacy.

  • Elective Rotations – 3 months

    Elective rotations can be tailored to the resident’s interests. Offerings include any of the previously mentioned required rotations or additional ambulatory care and acute care rotations including cardiology, cardiac intensive care, inpatient family medicine, bone marrow transplant, emergency medicine, clinical toxicology, neonatal intensive care, pediatric hematology/oncology, pediatric cardiovascular intensive care unit, outpatient hematology/oncology, and solid organ transplant.  Residents will also have the potential to work with residency preceptors to develop additional learning experiences based on specific interest area.

  • Research – 1 month and longitudinal

    Residents complete a research curriculum which includes the University of Oklahoma Health Sciences Center Institutional Review Board (IRB) certification for conducting human research and specific research training sessions through Resident Rounds. Each resident designs and executes an original research project under the mentorship of their research committee, which consists of the residency program director, an expert in the practice area in which research will be conducted, and an expert in study design, data analysis, and statistical methods. The research rotation occurs longitudinally from July through June; however, residents will also be scheduled for a one-month rotation to focus on data collection and analysis. Residents present preliminary research findings as a poster at the ASHP Midyear Clinical Meeting and final results as a podium presentation at the Oklahoma Residency Research Conference hosted by Oklahoma Society of Health-System Pharmacists. In accordance with ASHP standards, residents prepare a high-quality manuscript based on their research findings.

  • Teaching and Methodology - Longitudinal (12 months)

    The teaching and methodology longitudinal rotation consists of both didactic and experiential components designed to promote integration and application of various aspects of teaching and optimize learning through a variety of teaching experiences. The course coordinator and education specialist work closely with each resident to ensure adequate support in each of the teaching opportunities. Some of the required teaching activities include two didactic lectures, two sessions as an evaluator in a pharmacy practice lab, four sessions as a group facilitator for case-based discussions, and development of a teaching philosophy statement.

  • Ambulatory Continuity Clinic - Longitudinal (6 months)

    Continuity of care clinic experiences take place in the second half of the PGY1 pharmacy residency (January through June). Residents provide pharmaceutical care services to patients on a regular basis (usually one half-day weekly) in the same outpatient setting for a period of six months. This gives residents the opportunity to practice longitudinally in one setting and see patients on return visits to the clinic. Available experiences include management of diabetes, thromboembolic disorders, and infectious diseases (HIV).

  • Drug Information and Medication Use Evaluation - Longitudinal (12 months)

    Since the development of strong drug information skills is essential for pharmacy practitioners, this experience is longitudinal throughout the entire residency program. Residents participate in defined drug information activities, such as the completion of one drug information question, preparation of drug monographs for formulary consideration, presentation of an educational seminar for nurses or staff pharmacists, and development and presentation of at least one medication use evaluation (MUE).

  • Service Commitment and Investigational Drug Service - Longitudinal (12 months)

    As an integral component of the PGY1 pharmacy residency, PGY1 pharmacy residents learn to function independently as a staff pharmacist within the OU Health Department of Pharmacy (approximately every third weekend rotation). In the Fall semester, the resident will be exposed to and fulfill responsibilities of a staff clinical pharmacist in both the adult and the Children’s Hospital pharmacy.  In the Spring semester, the resident will be exposed to and fulfill the responsibilities of a clinical pharmacy specialist and perform clinical responsibilities such as vancomycin dosing, IV to PO changes, renal dose adjustments, anticoagulation, etc. In addition, residents participate in educational programs and departmental staff meetings as assigned. As part of the staffing responsibilities, residents will also be trained in the handling of investigational drug products and research protocols at OU Health.  

Residency Program Director

Jamie L. Miller, Pharm.D., BCPPS, FPPA

Professor of Pharmacy Practice at the University of Oklahoma College of Pharmacy
Practice Area – Neonatal Intensive Care

Residency Rotation Preceptors

  • Orientation to OU Health

    Kate Summers, Pharm.D

  • Practice Management

    Katie Thompson, Pharm.D., BCPS

  • Drug Information and Medication Use Evaluation

    Katie Thompson, Pharm.D., BCPS

  • Service Commitment and Investigational Drug Services

    Katie Thompson, Pharm.D., BCPS

    Kate Summers, Pharm.D.

  • Clinical Staffing Orientation

    Kate Summers, Pharm.D

  • Ambulatory Care (Anticoagulation and Diabetes)

    Susan Conway, Pharm.D., BCPS, FASHP

    Jamie Farley, Pharm.D., BCACP, BCPS, CDE

  • Ambulatory Care (Internal Medicine)

  • Outpatient Hematology/Oncology

    Marcus Tad Autry, Pharm.D., BCPS

    Brooke Deason, Pharm.D., BCOP

    Jennifer Steward, Pharm.D., BCOP

  • Clinical Toxicology

    Kristie Edelen, Pharm.D., CSPI

  • Acute Care

    Inpatient Internal Medicine

    Kiya Bennett, Pharm.D., BCPS

    Beth Resman-Targoff, Pharm.D., FCCP

    Corey Guidry, Pharm.D., BCPS

    Jordan Perrine, Pharm.D., MBA, BCPS

    Adult Bone Marrow Transplant

    Matthew Daniels, Pharm.D.

    Cardiac Intensive Care

    Kara Kubbs, Pharm.D.

    Emergency Medicine

    Rachel Boardman, Pharm.D.

    Shane Salimnejad, Pharm.D., BCPS

    Inpatient Infectious Diseases

    Bryan White, Pharm.D., BCPS

    Emily Siegrist, Pharm.D.

    Inpatient and Outpatient Family Medicine

    Mary Shreffler, Pharm.D., BCPS

    Medical Intensive Care Unit

    Jordan Perrine, Pharm.D., MBA, BCPS

    Kate Summers, Pharm.D.


    Peter Johnson, Pharm.D., BCPS, BCPPS, FPPA, FCCM

    Teresa Lewis, Pharm.D., BCPS

    Jamie Miller, Pharm.D., BCPS, BCPPS, FPPA

    Misty Miller, Pharm.D., BCPS, AAHIVP

    Maura Harkin, Pharm.D.

    Katy Stephens, Pharm.D.

    Inpatient Pediatric Hematology/Oncology

    Jonna Kemper, Pharm.D.

    Outpatient Pediatric Hematology/Oncology

    Whitney Bueno, Pharm.D., BCOP

    Solid Organ Transplant

    Phu Nguyen, Pharm.D., BCPS

    Trauma Intensive Care Unit

    Janice Tsui, Pharm.D., BCPS

  • Teaching and Methodology

    Melissa S. Medina, Ed.D.

  • Current Residents

    Taylor Fallin, Pharm.D.

    Avery Parman, Pharm.D.

    Dominique Ropp, Pharm.D.

  • Residency Program Alumni


    Eugenie Chang, Pharm.D.
    PGY2 Pediatric Pharmacy Resident, University of Oklahoma College of Pharmacy, Oklahoma City, OK

    Lauren Sinko, Pharm.D.
    PGY2 Oncology Resident, University of Oklahoma College of Pharmacy, Oklahoma City, OK

    Taylor Zelnicek, Pharm.D.
    PGY2 Ambulatory Care Resident, University of Oklahoma College of Pharmacy, Oklahoma City, OK


    Caitlyn Bradford, Pharm.D.
    Assistant Professor, Philadelphia College of Pharmacy, Philadelphia, PA

    Becky Mayes, Pharm.D.
    Critical Care Pharmacy Specialist, OU Health, Oklahoma City, OK


    Trager Hintze, Pharm.D.
    Clinical Assistant Professor, Texas A&M Irma Lerma Rangel College of Pharmacy, Kingsville, TX

    Amber Thomas, Pharm.D.
    Clinical Pharmacy Specialist – Cystic Fibrosis Clinic, University Health, San Antonio, TX


    Maura Harkin, Pharm.D.
    Pediatric Clinical Pharmacy Specialist—PICU, The Children’s Hospital at OU Health; Oklahoma City, OK

    Dillon Hayden, Pharm.D.
    Gynecology/Oncology Clinical Specialist, OU Health, Oklahoma City, OK


    Morgan Alonzo, Pharm.D.
    Clinical Ambulatory Care Pharmacist, Endocrinology Clinic at Colorado Children's Hospital; Aurora, CO

    Kate Newman, Pharm.D.
    Ambulatory Care Clinical Pharmacist, Evergreen Health; Kirkland, WA


    Tad Autry, Pharm.D.
    Clinical Pharmacist, OU Health Stephenson Cancer Center; Oklahoma City, OK

    Sin Yin (Sean) Lim, Pharm.D.
    Assistant Professor, Pharmacy Practice Division, School of Pharmacy; University of Wisconsin-Madison


    Jennifer Dannelley, Pharm.D.
    Pediatric Clinical Pharmacist, University of Oklahoma College of Medicine; Oklahoma City, OK

    Ashley Fox, Pharm.D., BCPS Internal Medicine Clinical Specialist, University of New Mexico Hospital, Albuquerque, NM


    Amanda Capino, Pharm.D.
    Clinical Assistant Professor, University of Mississippi College of Pharmacy; Jackson, MS

    Jennifer Tieu, Pharm.D.
    Clinical Pharmacist, SSM St. Anthony Hospital; Oklahoma City, OK


    Joseph Van Tuyl, Pharm.D.
    Associate Professor, St. Louis College of Pharmacy; St. Louis, MO

    Cheng Yuet, Pharm.D.

    Clinical Pharmacist – Outpatient pharmacy, Southeast Tarrant County Medical Home, JPS Health Network, Arlington, TX


    Bethany Ibach, Pharm.D.
    Assistant Professor, Texas Tech School of Pharmacy; Abilene, TX

    Ryan Tomlin, Pharm.D.
    Clinical Pharmacist, Mercy Health Infectious Disease Clinic; Grand Rapids, MI


    Megan Andrews Carroll, Pharm.D.

    Mackenzie Cottrell, Pharm.D., M.S.
    Assistant Professor, University of North Carolina Eshelman School of Pharmacy; Chapel Hill, NC


    Christina Bulkley, Pharm.D.
    Graduate Student, Social/Administrative Sciences, University of Oklahoma College of Pharmacy; Oklahoma City, OK

    Candace Hooper, Pharm.D.
    Clinical Pharmacist, Baylor All-Saints Medical Center; Fort Worth, TX


    Holly Herring, Pharm.D.
    Associate Vice President of Pharmacy, OU Health; Oklahoma City, OK

    Misty Miller, Pharm.D.
    Associate Professor, HIV/Infectious Diseases, University of Oklahoma College of Pharmacy; Oklahoma City, OK

    Ashley Teel, Pharm.D.
    Clinical Pharmacist, Pharmacy Management Consultants, University of Oklahoma College of Pharmacy; Oklahoma City, OK


    Russell Benefield, Pharm.D., BCPS
    Clinical Pharmacy Specialist, Infectious Diseases, University of Utah Pharmacy Services; Salt Lake City, UT

    Rebecca Dunn, Pharm.D., BCPS
    Clinical Assistant Professor, Ben and Maytee Fisch College of Pharmacy; Tyler, TX

    Emily Gish Benefield, Pharm.D., BCPS
    Advanced Clinical Pharmacist, Primary Children’s Medical Center; Salt Lake City, UT


    Brooke Gildon, Pharm.D., BCPS, AE-C
    Professor, Pediatrics, Southwestern Oklahoma State University College of Pharmacy; Weatherford, OK

    Jamie Farley, Pharm.D., BCPS
    Clinical Assistant Professor, Ambulatory Care, University of Oklahoma College of Pharmacy; Oklahoma City, OK

    Tiffany Kessler, Pharm.D., BCPS
    Associate Professor of Pharmacy Practice, Internal Medicine, Southwestern Oklahoma State University College of Pharmacy; Weatherford, OK


    Matthew Bird, Pharm.D., BCPS
    Medical Science Liaison, Astra Zeneca Pharmaceuticals; Oklahoma City, OK

    Emily Borders, Pharm.D., BCOP
    Assistant Professor, Department of Pharmacy Practice, Southwester Oklahoma State University College of Pharmacy; Weatherford, OK

    Kaysey Cloud, Pharm.D., BCPS
    Clinical Pharmacist, Texas Health Harris Methodist Hospital Fort Worth; Fort Worth, TX

    Jessica Cottreau, Pharm.D.
    Associate Professor, Rosalind Franklin University; Chicago, IL

    Jamie Miller, Pharm.D., BCPS, BCPPS
    Professor, Pediatrics, University of Oklahoma College of Pharmacy; Oklahoma City, OK


    Gwen Bisek, Pharm.D.
    Clinical Pharmacist, Abbott Northwestern Hospital; Minneapolis, MN

    Jatandra Owens Birney, Pharm.D.
    Clinical Pharmacist, Inpatient Oncology Service University of Utah-Huntsman Cancer Center; Salt Lake City, UT

    Katy Mathews Cox, Pharm.D., BCPS-AQ Cardiology
    Critical Care Pharmacist, Cardiology, Baylor University Medical Center, Department of Pharmacy; Dallas, TX


    Shaunta’ Martina Ray, Pharm.D., BCPS
    Associate Professor, Internal Medicine, University of Tennessee College of Pharmacy; Knoxville, TN

    Tamara Mlekoday, Pharm.D.
    Emergency Department Pharmacy Specialist, Integris Baptist Medical Center; Oklahoma City, OK

    Erica Smith, Pharm.D.
    Pharmacy Specialist, Integris Southwest Medical Center; Oklahoma City, OK

    Dena Stout, Pharm.D.
    Drug Information Specialist, William Beaumont Hospital; Troy, MI

    Tracy Watson, Pharm.D.
    Lead Evening Pharmacist, Deaconess Hospital; Oklahoma City, OK

  • Accreditation


    This residency program is accredited by the American Society of Health-System Pharmacists